Three questions about osteoporosis in peri- and postmenopause: where is the truth?
Problems of prevention and therapy of consequences of irreversible bone tissue loss in menopausal women are discussed. The authors believe that the pathogenetic-substantiated prevention of osteoporosis and pathological fractures in peri- and postmenopausal women, aimed at slowing the mechanisms of bone resorption at the stage of relatively intact capacity for adequate bone formation, provided by recovery of still moderate estrogen deficiency by using hormone replacement therapy is most effective. At the same time the diet correction in the direction of full consumption of products containing calcium, phosphorus and magnesium, active lifestyle with regular physical activity, renunciation of social habits are also required.

Keywords: bisphosphonates, perimenopause, bone density, osteoporosis, hormone replacement therapy, postmenopause, calcium